Lv11
88 积分 2025-07-11 加入
First-in-Human Dose-Escalation Study of the First-in-Class PDE3A–SLFN12 Complex Inducer BAY 2666605 in Patients with Advanced Solid Tumors Coexpressing SLFN12 and PDE3A
3小时前
待确认
Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites
20天前
已完结
Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist
20天前
已完结
Advancing clinical response against glioblastoma: Evaluating SHP1705 CRY2 activator efficacy in preclinical models and safety in phase I trials
25天前
已完结
Circadian disruption in cancer hallmarks: Novel insight into the molecular mechanisms of tumorigenesis and cancer treatment
25天前
已完结
Integrating cancer medicine into metabolic rhythms
26天前
已完结
Mitochondrial disease
1个月前
已完结
Pannexin channels and their links to human disease
1个月前
已完结
Cooperation between SIX1 and DHX9 transcriptionally regulates integrin-focal adhesion signaling mediated metastasis and sunitinib resistance in KIRC
1个月前
已完结
Workflow for E3 Ligase Ligand Validation for PROTAC Development
1个月前
已完结
皖公网安备34019202002308
